Why the study?
Does echocardiographic pulmonary acceleration time (PAcT) accurately identify raised pulmonary vascular resistance compared to right heart catheterization in patients with suspected pulmonary hypertension?
Does echocardiographic pulmonary acceleration time (PAcT) accurately identify raised pulmonary vascular resistance compared to right heart catheterization in patients with suspected pulmonary hypertension?
A pulmonary acceleration time of ≤90 ms on echocardiography is a strong non-invasive predictor of raised pulmonary vascular resistance (>3 WU), helping differentiate pre- and post-capillary pulmonary hypertension.
Answers are grounded in this paper and cite their sources.
May aid noninvasive PVR estimation; leaves open prospective validation against catheterization.
BACKGROUND: In patients with pulmonary hypertension (PH), ascertaining raised vascular resistance as a cause is a clinical objective, for which various Doppler-based measurements have been proposed, but with modest accuracy. We hypothesize that pulmonary acceleration time (PAcT) and the ratio of PAcT/peak pulmonary artery systolic pressure (PASP) reflect better the extent of the vascular resistance, compared with other available methods, and can differentiate accurately between pre- and post-capillary PH. METHODS AND RESULTS: We investigated 56 patients (mean age 61 ± 13 years, 23 males) in a simultaneous echocardiography and right heart catheterization (RHC) study. Based on the RHC, pulmonary vascular resistance (PVR), and pulmonary capillary wedge pressure (PCWP), patients were divided into four groups: Group 1 = normal PVR [<3 WU (Wood units)] and PCWP (<12 mmHg), Group 2 = raised PVR but normal PCWP, Group 3 = raised PVR and PCWP; and Group 4 = normal PVR but raised PCWP. We used spectral Doppler to measure PAcT (corrected for heart rate) and to estimate PASP (peak tricuspid regurgitation pressure drop + estimated right atrial pressure of 7 mmHg). We also tested other available methods for assessing PVR. There were small age differences between patient groups but no age difference between Groups 2 and 4. PAcT and PAcT/PASP were both significantly (P = 0.008) reduced in Groups 2 and 3 compared with Groups 1 and 4. PAcT ≤90 had an 84% sensitivity and an 85% specificity in identifying patients with PVR ≥3 WU with a positive and a negative predictive value of 88% and 81%, respectively. The non-linear relationship between PVR and PAcT gave a quadratic r = 0.61, P < 0.001. ROC curve analysis showed PAcT having the best accuracy (83%) in detecting a PVR ≥3 WU. CONCLUSION: PAcT <90 ms can serve as a strong non-invasive predictor of PVR >3 WU, which could differentiate patients with pre- and post-capillary PH.
No takes yet. Share an insight, caveat, or question.
Tossavainen et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: